Location Granada, Andalucia, Spain Regions European Union (EU), Europe, Middle East, and Africa (EMEA) Gender Male
Website www.dxna.com/ LinkedIn View on LinkedIn
Todd Snowden joined DxNA in January 2014 following the acquisition by DxNA of PathoGene, a molecular diagnostic development company where Todd was President and CEO. Todd was brought in to PathoGene to raise initial funding, in-license technology, drive the development of the companies first molecular assays and to out-license these assays. Prior
to PathoGene Todd was President and CEO of Ascent Business Advisors, a consulting firm focused on development and commercialization strategies for biotechnology and medical device companies, developing products, value propositions and strategies that deliver high margin revenue. In addition, Todd has 25 years of experience in the US and Europe in sales, business development, product management, sales and marketing management, and general business management roles primarily in medical diagnostics, medical laboratory services and medical device companies ranging in size from start-up to Fortune 500. Todd received his Bachelors Degree in Bioengineering from the Catholic University of America.
